U.S. health regulators have approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease. The Food and Drug Administration approved Biogen s infused drug for patients with a rare
WASHINGTON (AP) — Food and Drug Administration regulators on Tuesday approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease, though they are requiring further research to confirm